Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes.
Groh M, Rohmer J, Etienne N, Abou Chahla W, Baudet A, Chan Hew Wai A, Chenivesse C, Clisson Rusek I, Cottin V, Decamp M, De Groote P, Delahousse F, Duployez N, Faguer S, Gottrand F, Huang F, Leblanc T, Magnan A, Martin T, Mortuaire G, Néel A, Paris L, Petit A, Rossignol J, Schleinitz N, Soret-Dulphy J, Staumont-Salle D, Terrier B, Terriou L, Viallard JF, Lefèvre G, Kahn JE. Groh M, et al. Among authors: chenivesse c. Orphanet J Rare Dis. 2023 Apr 30;18(1):100. doi: 10.1186/s13023-023-02696-4. Orphanet J Rare Dis. 2023. PMID: 37122022 Free PMC article.
Targeting IL-5/5R for the treatment of idiopathic chronic eosinophilic pneumonia.
Delcros Q, Taillé C, Vallée A, Brun AL, Chenivesse C, Couture P, Daboussi S, Guilleminault L, Juster F, Kahn JE, Lefèvre G, Liozon E, Magnan A, Meireles S, Moulis G, Puech C, Tcherakian C, Traclet J, Uzunhan Y, Cottin V, Groh M; CEREO, OrphaLung, and CRISALIS Networks. Delcros Q, et al. Among authors: chenivesse c. J Allergy Clin Immunol Pract. 2023 Apr;11(4):1317-1319.e1. doi: 10.1016/j.jaip.2022.12.022. Epub 2022 Dec 26. J Allergy Clin Immunol Pract. 2023. PMID: 36581069 No abstract available.
Allergic bronchopulmonary aspergillosis: A multidisciplinary review.
Roboubi A, Audousset C, Fréalle É, Brun AL, Laurent F, Vitte J, Mortuaire G, Lefevre G, Cadranel J, Chenivesse C. Roboubi A, et al. Among authors: chenivesse c. J Mycol Med. 2023 Aug;33(3):101392. doi: 10.1016/j.mycmed.2023.101392. Epub 2023 May 4. J Mycol Med. 2023. PMID: 37172543 Review.
[Idiopathic pulmonary fibrosis: Desperately seeking a model].
Hennion N, Chenivesse C, Humez S, Gottrand F, Desseyn JL, Gouyer V. Hennion N, et al. Among authors: chenivesse c. Rev Mal Respir. 2024 Apr;41(4):274-278. doi: 10.1016/j.rmr.2024.02.009. Epub 2024 Mar 12. Rev Mal Respir. 2024. PMID: 38480096 Review. French.
Oncostatin-M Is Produced by Human Eosinophils and Expression Is Increased in Uncontrolled Severe Asthma.
Esnault S, Bernau K, Floerke HL, Dendooven A, Delaunay E, Dill-McFarland KA, Altman MC, Busse WW, Rosenkranz MA, Tattersall MC, Johansson MW, Labreuche J, Beury D, Sebda S, Dezoteux F, Segard B, Mortuaire G, Staumont-Sallé D, Stoup T, Chenivesse C, Sandbo N, Jarjour NN, Lefèvre G. Esnault S, et al. Among authors: chenivesse c. Allergy. 2024 Dec 21. doi: 10.1111/all.16453. Online ahead of print. Allergy. 2024. PMID: 39707874 No abstract available.
Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial.
Godet C, Couturaud F, Marchand-Adam S, Pison C, Gagnadoux F, Blanchard E, Taillé C, Philippe B, Hirschi S, Andréjak C, Bourdin A, Chenivesse C, Dominique S, Bassinet L, Murris-Espin M, Rivière F, Garcia G, Caillaud D, Blanc FX, Goupil F, Bergeron A, Gondouin A, Frat JP, Flament T, Camara B, Priou P, Brun AL, Laurent F, Ragot S, Cadranel J; NebuLamB study group and GREPI network; Godet C, Couturaud F, Cadranel J, Frat JP, Brun AL, Laurent F, Marchand-Adam S, Pison C, Gagnadoux F, Blanchard E, Taillé C, Philippe B, Hirschi S, Andréjak C, Chenivesse C, Dominique S, Bassinet L, Murris-Espin M, Rivière F, Garcia G, Caillaud D, Blanc FX, Goupil F, Gondouin A, Flament T, Camara B, Priou P, Ragot S. Godet C, et al. Among authors: chenivesse c. Eur Respir J. 2022 Jun 16;59(6):2102218. doi: 10.1183/13993003.02218-2021. Print 2022 Jun. Eur Respir J. 2022. PMID: 34764182 Free article. Clinical Trial.
Proteomic profiling of serum identifies a molecular signature that correlates with clinical outcomes in COPD.
Dagher R, Fogel P, Wang J, Soussan D, Chiang CC, Kearley J, Muthas D, Taillé C, Berger P, Bourdin A, Chenivesse C, Leroy S, Anderson G, Humbles AA, Aubier M, Kolbeck R, Pretolani M; COBRA Consortium. Dagher R, et al. Among authors: chenivesse c. PLoS One. 2022 Dec 8;17(12):e0277357. doi: 10.1371/journal.pone.0277357. eCollection 2022. PLoS One. 2022. PMID: 36480517 Free PMC article.
Anti-IL-4R versus anti-IL-5/5R after anti-IL-5/5R failure in asthma: An emulated target trial.
Valery S, Simon-Tillaux N, Devouassoux G, Bonniaud P, Beurnier A, Boudjemaa A, Chenivesse C, Bourdin A, Gauquelin L, Guillo S, Taillé C, Estellat C; RAMSES Study Group. Valery S, et al. Among authors: chenivesse c. J Allergy Clin Immunol. 2024 Oct;154(4):922-932. doi: 10.1016/j.jaci.2024.05.023. Epub 2024 Jun 6. J Allergy Clin Immunol. 2024. PMID: 38848878 Clinical Trial.
125 results